News

Middlefield Healthcare ETF Announces Q3 Distributions in 2025

Middlefield Healthcare ETF Announces Q3 Distributions in 2025

Exciting News from Middlefield Healthcare Dividend ETF

Middlefield Healthcare Dividend ETF (TSX: MHCD) has announced an exciting update regarding its distributions for unitholders. This announcement details the distributions for the upcoming third quarter, emphasizing the Fund's commitment to providing value to its investors. If you're a unitholder, you can look forward to receiving distributions that reflect the Fund's performance and overall market conditions.

Distribution Schedule for Q3 2025

The Fund has outlined its distribution schedule for the third quarter. Unitholders will receive distributions based on specific record dates, with particular emphasis on the payable dates:

Key Dates and Distribution Amount

Here are the key dates you should note:

  • Record Date: July 31, 2025 | Payable Date: August 15, 2025 | Distribution: $0.05 per Trust Unit
  • Record Date: August 31, 2025 | Payable Date: September 15, 2025 | Distribution: $0.05 per Trust Unit
  • Record Date: September 30, 2025 | Payable Date: October 15, 2025 | Distribution: $0.05 per Trust Unit

Understanding the Distribution Reinvestment Plan

Unitholders have the opportunity to enhance their investment through the Fund's distribution reinvestment plan (DRIP). This program enables you to automatically reinvest your distributions without incurring any commission fees. It’s a fantastic way to embrace the benefits of compound growth on your investment. If you’re interested in enrolling in the DRIP program, simply contact your investment advisor for details.

About Middlefield Group

Middlefield Group has a storied history, having been established in 1979. This renowned asset management company specializes in equity income, and with offices located both in Toronto and London, it has a global reach. The investment team at Middlefield is dedicated to active management and focuses on selecting high-quality companies across various sectors, including healthcare, infrastructure, energy, and more.

Investment Strategies and Product Offerings

Middlefield offers a range of investment strategies that focus on dividend generation. These strategies are tailored for various investor needs and include several product types, such as ETFs, Mutual Funds, and Closed-End Funds. The goal is to deliver strong returns through a comprehensive and thoughtful investment process.

With a reputation for selecting promising companies and focusing on growth sectors, the Middlefield Healthcare Dividend ETF serves as a vital option for investors looking to diversify their portfolios with healthcare investments while enjoying regular income through dividends. The stock trades on the Toronto Stock Exchange under the symbol MHCD.

Contact Information

For further inquiries or to delve deeper into the investment opportunities provided by Middlefield Healthcare, you can visit their website at www.middlefield.com or reach out directly to Nancy Tham from the Sales and Marketing Department at 1.888.890.1868.

Frequently Asked Questions

What is the significance of the record date?

The record date determines which unitholders are eligible to receive the upcoming distributions. Only those on the register by this date will receive the funds.

How can I reinvest my distributions?

By enrolling in the DRIP, you can automatically reinvest your distributions commission-free, allowing your investment to grow over time.

What are the benefits of investing in Middlefield Healthcare Dividend ETF?

Investing in this ETF allows you to gain exposure to high-quality healthcare companies while benefiting from regular income through dividends.

Can I trade my trust units at any time?

Yes, the trust units can be traded on the Toronto Stock Exchange, providing liquidity to investors.

How often are distributions paid?

Distributions are typically paid quarterly, following the established schedule communicated to unitholders.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

Updated Category News Views 15

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Continue Reading
Monster Energy Dominates Skateboard Podium at SLS Paris

Updated Category News Views 10

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

Continue Reading
SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Updated Category News Views 10

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Continue Reading
Monteverde Probes Four Key M&A Deals for Fairness

Updated Category News Views 23

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...

Continue Reading
Blokees Unveils 90+ New Wonders at Shanghai Fest

Updated Category News Views 7

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Continue Reading
Black Culture Icon: Plastic-Covered Couch Takes Stage

Updated Category News Views 14

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

Continue Reading
Lawsuit Highlights Inaction in School Bus Tragedy

Updated Category News Views 9

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...

Continue Reading
Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Updated Category News Views 11

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

Continue Reading
Class Action Alerts: M&A Under Scrutiny

Updated Category News Views 12

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Continue Reading
Power Knot MEA Wins THE BIZZ 2026 for Excellence

Updated Category News Views 10

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Continue Reading

Top 5 Most Recently Viewed Articles

SINTX Technologies Expands Antipathogenic Patent Portfolio for Growth

Updated Category News Views 131

SINTX Technologies Expands Antipathogenic Patent Portfolio New U.S. Patent reinforces competitive advantage and opens up more licensing and product opportunities. SINTX Technologies, Inc. (NASDAQ: SINT) is thrilled to share that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for an important patent related to the company’s...

Continue Reading
Alcoa's Strong Profit Surge Drives Share Price Upward

Updated Category News Views 58

Alcoa Corp Reports Impressive Third-Quarter Earnings Alcoa Corp (NYSE: AA) has posted remarkable third-quarter earnings that exceeded analyst expectations, resulting in a notable 5.4% increase in its share price during after-hours trading. The primary factors contributing to these positive results include rising alumina prices and decreasing costs for raw materials, which...

Continue Reading
Investor Rights and Legal Options for Shareholders Explained

Updated Category News Views 197

Understanding Shareholder Rights and Legal Recourse Shareholders are urged to reach out to the firm promptly, as opportunities to protect your rights may be time-sensitive. Halper Sadeh LLC is a prominent law firm dedicated to protecting investor rights and is actively investigating notable transactions that may raise potential securities law violations. Among the...

Continue Reading
Crescent Real Estate Launches Exclusive Atten Hill Development

Updated Category News Views 303

Crescent Real Estate Launches New Exclusive Development Crescent Real Estate LLC, a prominent name in the real estate industry, has recently made headlines with its groundbreaking announcement. The company is set to introduce a premium residential project known as Atten Hill. This exceptional development aims to provide an exclusive experience to its future residents,...

Continue Reading
Merck's Winrevair Significantly Reduces Risk in PAH Patients

Updated Category News Views 262

Merck's Clinical Breakthrough with Winrevair Merck & Co. Inc. (NYSE: MRK) has made significant strides in treating pulmonary arterial hypertension (PAH) through its groundbreaking drug, Winrevair (sotatercept-csrk). Recent findings from a Phase 3 clinical trial known as HYPERION reveal that Winrevair drastically reduces the risk of clinical worsening by 76%. This...

Continue Reading